VELOCITY FUND PARTNERS, LP - 31 Dec 2024 Form 3/A - Amendment Insider Report for Medicus Pharma Ltd. (MDCX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
3/A - Amendment
Accepted by SEC
21 May 2025, 16:21:04 UTC
Original report date
31 Dec 2024
Next SEC filing
21 May 2025
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP

Key filing fact

VELOCITY FUND PARTNERS, LP filed Form 3/A - Amendment for Medicus Pharma Ltd. (MDCX) on 21 May 2025.

Key facts

  • This page summarizes VELOCITY FUND PARTNERS, LP's Form 3/A - Amendment filing for Medicus Pharma Ltd. (MDCX).
  • 0 reported transactions and 0 derivative rows are listed below.
  • Accepted by SEC: 21 May 2025, 16:21.

Change

  • No earlier filing in this sequence is available for direct comparison.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3/A - Amendment disclosures.

View source filing

Reporting Owners (2)

CIK 0001671948 Primary reporting owner

VELOCITY FUND PARTNERS, LP

Relationship
10%+ Owner
Address
1100 STONEGATE MANOR, CHESWICK
Signature
/s/ Kenneth R. Melani, General Partner of Velocity Fund Partners, LP
Signature date
21 May 2025
CIK 0002050471

Melani Kenneth R.

Relationship
10%+ Owner
Address
1100 STONEGATE MANOR, CHESWICK
Signature
/s/ Kenneth R. Melani
Signature date
21 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MDCX holding

Common Shares, no par value ("Common Shares")

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
2,914,330
Date
31 Dec 2024
Ownership
See Footnote
Footnotes
F1
MDCX holding

Common Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
409,411
Date
31 Dec 2024
Ownership
Direct
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Held by Velocity Fund Partners, LP, an entity controlled by Dr. Kenneth R. Melani. Dr. Kenneth R. Melani disclaims beneficial ownership except to the extent of his pecuniary interest therein.

SEC remarks

The initial Form 3 that was filed on December 31, 2024, is being amended solely to add Velocity Fund Partners, LP as a Reporting Owner.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .